|
Orthologous residues
|
|
H3F3A (human): S11‑p, H3F3A (mouse): S11‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
phospho-antibody
|
|
Disease tissue studied:
brain cancer, glioblastoma, glioblastoma multiforme, glioma
|
|
Relevant cell lines - cell types - tissues:
T98G (glial)
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
human
|
|
Upstream Regulation
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
phorbol ester, serum
|
|
|
|
decrease
|
|
|
|
Downstream Regulation
|
|
Effect of modification (function):
activation
|
|
Effect of modification (process):
transcription, altered
|
